# Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition

> **NCT04051840** · PHASE1 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Nutritional Supplement Toxicity

## Interventions

- **DRUG:** ClinOleic (Baxter Healthcare, Deerfield, IL, USA)

## Key facts

- **NCT ID:** NCT04051840
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04051840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04051840, "Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04051840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*